Prevalence of Adenosine Deaminase (ADA) Enzyme Deficiency Disease in Adult Patients With Pulmonary Alveolar Proteinosis
- Conditions
- Pulmonary Alveolar Proteinosis
- First Posted Date
- 2022-03-29
- Last Posted Date
- 2022-03-29
- Lead Sponsor
- TRPHARM
- Target Recruit Count
- 15
- Registration Number
- NCT05300360
- Locations
- 🇹🇷
Istanbul Yedikule Chest Diseases and Thoracic Surgery Training and Research Hospital, Istanbul, Maltepe, Turkey
Investigation of ADA Enzyme Deficiency
- Conditions
- Adenosine Deaminase Deficiency
- First Posted Date
- 2022-03-29
- Last Posted Date
- 2022-03-29
- Lead Sponsor
- TRPHARM
- Target Recruit Count
- 800
- Registration Number
- NCT05300334
- Locations
- 🇹🇷
Ankara Üniversitesi Tıp Fakültesi, Ankara, Mamak, Turkey
Observational Study Evaluating the Prevalence of Enzyme Deficiency in Pulmonology Clinics (ADA)
- Conditions
- BronchiectasisAdenosine Deaminase DeficiencyPulmonary Disease
- First Posted Date
- 2022-03-29
- Last Posted Date
- 2022-03-29
- Lead Sponsor
- TRPHARM
- Target Recruit Count
- 500
- Registration Number
- NCT05300347
- Locations
- 🇹🇷
Ankara University Medical Faculty, Ankara, Mamak, Turkey
Evaluation of Adenosine Deaminase (ADA) Enzyme Deficiency in Patients With Lymphopenia and/or Elevated Immunoglobulin E
- Conditions
- Adenosine Deaminase Deficiency
- First Posted Date
- 2022-03-29
- Last Posted Date
- 2022-03-29
- Lead Sponsor
- TRPHARM
- Target Recruit Count
- 100
- Registration Number
- NCT05300373
- Locations
- 🇹🇷
Konya Necmettin Erbakan University, Konya, Meram, Turkey
A Study on the Prevalence of Mutation of Cerebrotendinous Xanthomatosis (CTX)
- Conditions
- Xanthomatosis, Cerebrotendinous
- First Posted Date
- 2020-01-06
- Last Posted Date
- 2021-04-01
- Lead Sponsor
- TRPHARM
- Target Recruit Count
- 800
- Registration Number
- NCT04218006
- Locations
- 🇹🇷
Osmaniye / Index Case 1 Family Village, Osmaniye, Turkey
A Compassionate Use Program to Provide Access to Sodium Thiosulfate
- Conditions
- Cisplatin-Induced Hearing Loss in Children Who Had Standard-risk Hepatoblastoma
- First Posted Date
- 2019-10-21
- Last Posted Date
- 2021-09-16
- Lead Sponsor
- TRPHARM
- Registration Number
- NCT04132882
- Locations
- 🇹🇷
Ankara University School of Medicine, Ankara, Turkey
An Observational Study for Evaluation of for the Prevalence of Cerebrotendinous Xanthomatosis (CTX) Disease
- Conditions
- CTX - Cerebrotendinous Xanthomatosis
- First Posted Date
- 2019-10-02
- Last Posted Date
- 2022-06-15
- Lead Sponsor
- TRPHARM
- Target Recruit Count
- 22
- Registration Number
- NCT04113083
- Locations
- 🇹🇷
Çukurova University Medical Faculty Deparment of Metabolism, Adana, Turkey
🇹🇷Çukurova University Medical Faculty Department of Neurology, Adana, Turkey
🇹🇷Ankara Child and Heamatology Hospital Deparment of Metabolism, Ankara, Turkey
The Prevalence of CTX Disorder in Juvenile Cataract Cases in Turkey
- Conditions
- Cerebrotendinous Xanthomatosis
- Interventions
- Procedure: Blood sampling for Cholestanol Analysis
- First Posted Date
- 2018-07-12
- Last Posted Date
- 2021-03-29
- Lead Sponsor
- TRPHARM
- Target Recruit Count
- 1000
- Registration Number
- NCT03584893
- Locations
- 🇹🇷
Dünya Göz Hospital, Ankara, Turkey
🇹🇷Akdeniz University Medical Faculty Department of Ophtalmology, Antalya, Turkey
🇹🇷Dicle University School of Medicine, Diyarbakır, Turkey
Bioequivalence and Safety Study of Bevacizumab-biosimilar (RPH-001) Compared to Bevacizumab-innovator
- Conditions
- Healthy
- Interventions
- Biological: Avastin®Biological: RPH001
- First Posted Date
- 2017-04-27
- Last Posted Date
- 2018-04-12
- Lead Sponsor
- TRPHARM
- Registration Number
- NCT03131700